Optimizing Cigna Enhertu Prior Authorization Workflows

Navigating **Cigna Enhertu prior authorization** requires precision across both medical and pharmacy benefits to ensure timely patient access to this critical oncology therapy.

For revenue cycle directors and prior authorization coordinators, managing high-volume specialty drug PAs like Enhertu through Cigna Healthcare and Evernorth can be complex. Klivira's platform is engineered to streamline these intricate workflows, reducing administrative burden and accelerating approval times for your clinic or health system.

Enhertu Prior Authorization Landscape with Cigna Healthcare

Enhertu is a critical oncology medication often requiring prior authorization across commercial and Medicare Advantage plans. For providers, understanding Cigna Healthcare's specific requirements is essential for efficient patient care. This includes distinguishing between medical and pharmacy benefit submissions and the relevant channels for each.

Cigna Submission Channels for Enhertu

**Medical Benefit (Infusion)**: Submissions for Enhertu administered under the medical benefit are routed through CignaforHCP.com, Cigna Healthcare's provider portal (src: cigna-hcp). X12 278 transactions are also accepted via clearinghouses.
**Pharmacy Benefit (Specialty Pharmacy)**: When Enhertu is processed under the pharmacy benefit, prior authorization is managed by Evernorth's Express Scripts, with specialty pharmacy services often provided by Accredo (src: express-scripts, accredo).
**Electronic Prior Authorization (ePA)**: Express Scripts supports ePA for pharmacy benefit submissions via established partners like CoverMyMeds and Surescripts for prescriber-initiated workflows (src: CoverMyMeds, Surescripts).
**Documentation**: The CignaforHCP portal supports member lookup, PA initiation, and document upload for medical benefit requests.

Cigna's Utilization Management Policies for Oncology Drugs

Cigna Healthcare publishes comprehensive coverage policies and medical necessity guidelines on its public provider site (src: cigna-coverage-positions). For oncology drugs like Enhertu, these policies often reference compendium-grounded criteria, such as those from NCCN, to establish medical necessity. Klivira's platform integrates with these policy libraries to inform submission logic.

Navigating Enhertu Prior Authorization Turnaround Times

Prior authorization turnaround times for Enhertu under Cigna Healthcare are influenced by state insurance regulations for commercial plans and payer-published service-level targets. For Medicare Advantage plans, Cigna Healthcare is a directly impacted payer under CMS-0057-F, which mandates 72-hour standard and 24-hour expedited PA timeframes (src: cms-0057-f).

Electronic Prior Authorization (ePA) and Da Vinci Project Engagement

Cigna Healthcare participates in the HL7 Da Vinci Project ecosystem, indicating a commitment to advancing electronic prior authorization (ePA) capabilities. Beyond this, Evernorth's Express Scripts has long-established ePA functionality through partners like CoverMyMeds and Surescripts, facilitating digital submissions for pharmacy benefit drugs like Enhertu.

Common Denial Reasons and Appeal Pathways for Enhertu

Denials for Enhertu prior authorizations from Cigna Healthcare and Evernorth typically stem from medical necessity criteria not met, insufficient documentation, or step therapy requirements. Denials are communicated via X12 277/835 or CignaforHCP portal updates. Klivira helps identify these patterns. Appeal pathways, including peer-to-peer reviews for clinical denials, are documented on the provider portal and vary by line of business.

Frequently asked questions

Which Cigna entity handles Enhertu prior authorization?

Prior authorization for Enhertu depends on the benefit it falls under. For medical benefit (infusion), Cigna Healthcare manages the PA through CignaforHCP.com. For pharmacy benefit, Evernorth's Express Scripts handles it, with specialty pharmacy services often provided by Accredo.

Can I submit Enhertu PAs electronically to Cigna?

Yes, electronic submission is available. For medical benefit, X12 278 transactions are accepted. For pharmacy benefit, Evernorth's Express Scripts utilizes ePA platforms such as CoverMyMeds and Surescripts for prescriber-initiated workflows.

What are common reasons for Enhertu PA denials from Cigna Healthcare?

Common denial reasons include insufficient documentation to meet medical necessity criteria, failure to satisfy step therapy requirements, or site-of-service mismatches. Klivira's platform assists in proactively addressing these issues.

How does Klivira help with Cigna Enhertu prior authorization?

Klivira automates the submission process by integrating with CignaforHCP.com and connecting to Evernorth's ePA channels. Our platform helps ensure all required documentation is complete, aligns submissions with Cigna's medical policies, and provides real-time status tracking to reduce manual effort and accelerate approvals.

Are there different turnaround times for Enhertu PAs with Cigna?

Yes, turnaround times vary. Commercial plans are subject to state-specific regulations, while Cigna Healthcare's Medicare Advantage plans adhere to CMS-0057-F mandates, requiring 72-hour standard and 24-hour expedited PA decisions.